Veronika Atkinson

Veronika Atkinson is a seasoned biostatistician with extensive experience in the field of clinical trials and data analysis. Currently serving as Principal Biostatistician at DCN Dx since February 2022, Veronika has previously held a similar role at Invivoscribe from 2012 to February 2022, where contributions included authoring over 200 research protocols and collaborating with bioinformatics teams on oncology MRD assays. Prior roles include Senior Biostatistician at Invivoscribe, Clinical Biostatistician at Prometheus Therapeutics and Diagnostics, and Biostatistician at Carl Zeiss Meditec, along with consulting positions in various healthcare organizations. Veronika holds a Master's degree in Applied Statistics from Purdue University and a Master's degree in Mechanics and Applied Mathematics from Novosibirsk State University.